Compound index

Estrogen Receptor Modulators

Enclomiphene

Late-stage human trialsInvestigational

Last reviewed: 2026-11-19

Evidence status & limitations

Human trials investigated endocrine outcomes, but approval of clomiphene does not constitute approval of enclomiphene.

Regulatory status

No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.

    Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

    WADA prohibited status: current list and context

    Known risks & open questions

    Visual symptoms, headache and endocrine changes are concerns; longer-term comparative safety remains uncertain.

    Key sources

    Identity and editorial screen completed November 19, 2026. A complete primary-source review is pending; literature-search links are labeled explicitly.

    Related glossary terms